ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

PCSA Processa Pharmaceuticals Inc

1,89
0,13 (7,39%)
24 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Processa Pharmaceuticals Inc PCSA NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,13 7,39% 1,89 20:00:57
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,76 1,76 1,83 1,80 1,76
mais cotações »

Notícias Recentes

Data Hora Fonte Título
06/05/202409:00GLOBEProcessa Pharmaceuticals to Participate in the EF Hutton..
30/04/202409:00GLOBEProcessa Pharmaceuticals Names Dr. Steven Cha Senior Vice..
11/04/202409:00GLOBEProcessa Pharmaceuticals Presents Two Abstracts at the AACR..
28/03/202409:15GLOBEProcessa Pharmaceuticals to Present at the MedInvest Biotech..
25/03/202409:15GLOBEProcessa Pharmaceuticals to Present Data at the American..
21/02/202410:15GLOBEProcessa Pharmaceuticals to Present at the 2024 BIO CEO &..
14/02/202415:00GLOBEProcessa Pharmaceuticals to Present at The Winter Wrap-Up..
06/02/202410:30GLOBEProcessa Pharmaceuticals Regains Compliance with Nasdaq..
01/02/202418:22GLOBEProcessa Pharmaceuticals Announces Closing of $7.0 Million..
26/01/202411:04GLOBEProcessa Pharmaceuticals Announces Pricing of $7.0 Million..
25/01/202410:30GLOBEProcessa Pharmaceuticals Announces Successful Completion of..
19/01/202409:45GLOBEProcessa Pharmaceuticals Announces Expansion of NGC-Cap..
18/01/202409:45GLOBEProcessa Pharmaceuticals to Effect a 1-for-20 Reverse Stock..
02/01/202419:06GLOBEProcessa Pharmaceuticals to Present at the Biotech Showcase..
19/12/202311:00GLOBEProcessa Pharmaceuticals Provides Interim Analysis from..
13/12/202311:00GLOBEProcessa Pharmaceuticals Announces Successful Phase 2..
30/11/202310:15GLOBEProcessa Pharmaceuticals to Present at the MedInvest..
29/11/202310:15GLOBEProcessa Pharmaceuticals Issues Letter to Shareholders..
13/11/202315:40GLOBEProcessa Pharmaceuticals, Inc. Mourns the Sudden Passing of..
09/11/202310:15GLOBEProcessa Pharmaceuticals to Present at the 20th Orphan Drugs..
01/11/202309:15GLOBEProcessa Pharmaceuticals Announces Formation of Oncology..
13/10/202314:08GLOBEProcessa Pharmaceuticals to Present at the ThinkEquity..
06/09/202309:15GLOBEProcessa Pharmaceuticals to Present at the H.C. Wainwright..
17/08/202309:05GLOBEProcessa Pharmaceuticals Provides Data Update Supporting a..
10/08/202317:15GLOBEProcessa Pharmaceuticals to Present at the Sidoti & Co...
08/08/202309:15GLOBEProcessa Pharmaceuticals Appoints Life Sciences Industry..
14/06/202317:15GLOBENext Generation Chemotherapy: Improved Treatment for More..